Table 2.
Overall | tPA | Placebo | |
---|---|---|---|
Prior stroke (%) | 12 | 12 | 12 |
Prior TIA (%) | 17 | 16 | 17 |
Aspirin use prior tostroke(%) | 35 | 40 | 29 |
Diabetes (%) | 21 | 21 | 22 |
Hypertension (%) | 64 | 65 | 63 |
Myocardial infarction (%) | 23 | 24 | 22 |
Atrial fibrillation (%) | 18 | 19 | 18 |
Angina (%) | 23 | 22 | 24 |
Congestive heart failure (%) | 17 | 15 | 20 |
Valvular heart disease (%) | 8 | 10 | 7 |
Smoking in prior year (%) | 34 | 33 | 35 |
SBP[mmHg ± SD,(range)] | 151.7±21.3 (90-227) |
152.4±22.0 (102-227) |
150.9±20.6 (90-200) |
DBP [mmHg ± SD, (range)] | 84.6±13.4 (10-134) |
84.1±12.8 (47-134) |
85.0±13.9 (10-120) |
MBP [mmHg ± SD, (range)] | 107.0±13.8 (51-161) |
107.0±13.9 (74-161) |
107.0±13.8 (51-153) |
Mean HR ( ± SD) | 81.8±17.4 (44-155) |
80.9±16.8 (44-136) |
82.6±17.8 (46-155) |